263 filings
Page 8 of 14
6-K
efgrqbg
14 Mar 19
ESSA Pharma to Attend the 31st Annual ROTH Conference
8:24am
6-K
3b0hs7jj xokb
19 Feb 19
Statement of Executive Compensation
4:07pm
6-K
w36fs7a
11 Feb 19
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
11:04am
6-K
yt7zkxg1cm4 igub
7 Feb 19
Condensed Consolidated Interim Financial Statements
5:27pm
6-K
8i0licw74pl r8c4971
13 Dec 18
Current report (foreign)
5:21pm
6-K
x3d4sa
6 Nov 18
Current report (foreign)
1:13pm
6-K
8fq q1mbq8uc
22 Oct 18
ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors
9:49am
6-K
mcikphdd22dwk03j
29 Aug 18
Current report (foreign)
12:00am
6-K
qcj0ve2
14 Aug 18
Condensed Consolidated Interim Financial Statements
7:18am
EFFECT
5yd5pd d8hcw
18 Jul 18
Notice of effectiveness
12:15am
F-3/A
6nif32d8owl0i s4i2nx
12 Jul 18
Shelf registration (foreign) (amended)
3:41pm
CORRESP
yu5z 11md1sk
12 Jul 18
Correspondence with SEC
12:00am
UPLOAD
1dh793ad3rpe3m1k1od6
5 Jul 18
Letter from SEC
12:00am
F-3
iy1cp7pq1xr6zvmy
28 Jun 18
Shelf registration (foreign)
5:22pm
6-K
p5mlesml7syj
25 May 18
Current report (foreign)
12:00am
S-8
woxe4jy927t lxw0
18 May 18
Registration of securities for employees
5:29pm
S-8 POS
7ttr5fd5ub skm0myo
18 May 18
Registration of securities for employees (post-effective amendment)
5:27pm
6-K
dbvla9ozylew8vgky2lx
15 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
i9da5pxshdvd
11 May 18
Current report (foreign)
12:00am